Close

Genetic Technologies (GENE), University of Melbourne Enter Development Agreement for Colorectal Cancer Risk Assessment Test

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. NVDA
4. META
5. PPG
6. HDFCB:IN
7. HDB
8. WIT
9. MSFT
10. HDFCAMC:IN


Go back to Genetic Technologies (GENE), University of Melbourne Enter Development Agreement for Colorectal Cancer Risk Assessment Test
Genetic Technologies Ltd. (NASDAQ: GENE) Delayed: 2.37 --0 (-0%)
Previous Close $2.37    52 Week High $4.27 
Open $2.37    52 Week Low $1.20 
Day High $2.37    P/E N/A 
Day Low $2.37    EPS $0.00 
Volume 1,422